LEVOMILNACIPRAN HYDROCHLORIDE

Search structure
Trade Names:
Synonyms:
Status: Approved (2013)
Entry Type: Small molecule
Molecule Category: Salt
UNII: 371U2ZK31U
Parent Compound: LEVOMILNACIPRAN

Structure
InChI Key XNCDYJFPRPDERF-NQQJLSKUSA-N
Smile CCN(CC)C(=O)[C@@]1(c2ccccc2)C[C@H]1CN.Cl
InChI
InChI=1S/C15H22N2O.ClH/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12;/h5-9,13H,3-4,10-11,16H2,1-2H3;1H/t13-,15+;/m0./s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C15H23ClN2O
Molecular Weight 282.81
AlogP 1.77
Hydrogen Bond Acceptor 2.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 5.0
Polar Surface Area 46.33
Molecular species BASE
Aromatic Rings 1.0
Heavy Atoms 18.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Norepinephrine transporter inhibitor DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Ischemic Stroke 3 D000083242 ClinicalTrials

Related Entries

Parent

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Psychiatric disorders
15.82
General disorders and administration site conditions
13.98
Nervous system disorders
13.23
Injury, poisoning and procedural complications
9.65
Gastrointestinal disorders
8.41
Cardiac disorders
6.37
Vascular disorders
5.57
Investigations
5.22
Skin and subcutaneous tissue disorders
4.53
Musculoskeletal and connective tissue disorders
4.18
Respiratory, thoracic and mediastinal disorders
2.69
Renal and urinary disorders
2.44

Cross References

Resources Reference
ChEMBL CHEMBL2105732
FDA SRS 371U2ZK31U
KEGG D10072
PubChem 6917778
SureChEMBL SCHEMBL1148742
ZINC ZINC00000506
CONTENTS